apomorphine
chemical compound
Facts
21 properties- Instance of
- type of chemical entity
- Subclass of
- aporphine alkaloids
- Has use
- medication[18]
- Active ingredient in
- Apokyn
- Canonical SMILES
- CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O[16]
- Chemical formula
- C₁₇H₁₇NO₂[17]
- Defined daily dose
- 20 mg, 2 mg
- Described by source
- Brockhaus and Efron Encyclopedic Dictionary, Great Soviet Encyclopedia (1926–1947)[38][39]
- Found in taxon
- Nymphaea caerulea[24]
- Isomeric SMILES
- CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(=C(C=C4)O)O
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- Mass
- 267.125929 Da
- Medical condition treated
- Parkinson's disease
- Physically interacts with
- 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C, Adrenoceptor alpha 2A, Adrenoceptor alpha 2B, Adrenoceptor alpha 2C, Dopamine receptor D1, Dopamine receptor D2, Dopamine receptor D3, Dopamine receptor D4, Dopamine receptor D5, Transient receptor potential cation channel subfamily A member 1[3][4][5][6][7][8][9][10][11][12][13][14][15]
- Pregnancy category
- Australian pregnancy category B3, US pregnancy category C
- Side effect
- nodule, somnolence, dizziness, fall, abscess, dyskinesia, orthostatic hypotension, hallucination, syncope, hemolytic anemia, impulse control disorder, peripheral edema, priapism[40][41]
- Significant drug interaction
- paliperidone, droperidol, haloperidol, chlorpromazine, tetrabenazine, pimozide, zuclopenthixol, ondansetron, sotalol, (RS)-sulpiride, aripiprazole, quetiapine, (R,R)-asenapine[25][26][27][28][29][30][31][32][33][34][35][36][37]
- Start time
- 1845[23]
- Stereoisomer of
- S(+)-apomorphine
- Subject has role
- dopamine agonist, emetic, antiparkinson
🏷️ Also known as
en (R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol
en Uprima®
en R-(-)-apomorphine
en (-)-10,11-dihydroxyaporphine
en (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
en Apokyn®
en apomorphine
en Ixense®
ar آبومورفين
cs Apomorfin
de Apomorphin
es Apomorfina
fa آپومرفین
fi apomorfiini
he אפומורפין
he פרומורפין
hi ऐपोमारफ़ीन
ja アポモルヒネ
ro Apomorfină
ru апоморфин
🔖 Identifiers · 53
- Library of Congress Authorities ID
- sh85006044
- OpenAlex ID
- C2777525119
- Brockhaus Enzyklopädie online ID
- apomorphin
- CAS Registry Number
- 58-00-4
- ChEBI ID
- 48538
- ChEMBL ID
- CHEMBL53
- ChemSpider ID
- 5783
- DSSTOX compound identifier
- DTXCID302614
- DSSTox substance ID
- DTXSID8022614
- De Agostini ID
- apomorfina
- DeCS ID
- 23948
Show all 53 identifiers +41
- DrugBank ID
- DB00714
- DrugCentral ID
- 228
- EC number
- 200-360-0
- ECHA Substance Infocard ID
- 100.000.327
- Encyclopaedia Beliana ID
- apomorfin
- Freebase ID
- /m/08hsmg
- Gran Enciclopèdia Catalana ID
- apomorfina
- Gran Enciclopèdia Catalana ID (former scheme)
- 0079696
- Guide to Pharmacology Ligand ID
- 33
- HSDB ID
- 3289
- Harper's tag
- apomorphine
- Human Metabolome Database ID
- HMDB0014852
- InChIKey
- VMWNQDUVQKEIOC-CYBMUJFWSA-N
- J9U entity ID
- 987007294032505171
- KEGG ID
- D07460
- LiverTox ID
- Apomorphine
- MassBank accession ID
- MSBNK-MPI_for_Chemical_Ecology-CE000031, MSBNK-MPI_for_Chemical_Ecology-CE000032, MSBNK-MPI_for_Chemical_Ecology-CE000033, MSBNK-MPI_for_Chemical_Ecology-CE000034, MSBNK-MPI_for_Chemical_Ecology-CE000035, MSBNK-IPB_Halle-PB005945, MSBNK-IPB_Halle-PB005946, MSBNK-IPB_Halle-PB005947, MSBNK-Waters-WA001973, MSBNK-Waters-WA001974, MSBNK-Waters-WA001975, MSBNK-Waters-WA001976, MSBNK-Waters-WA001977, MSBNK-Waters-WA001978
- MeSH concept ID
- M0001603
- MeSH descriptor ID
- D001058
- MeSH tree code
- D03.132.098.038.290, D03.633.100.531.085.030.290, D03.633.400.095.290
- Microsoft Academic ID (discontinued)
- 2777525119
- NALT ID
- 6446
- NDF-RT ID
- N0000147712
- PDB ligand ID
- OR9
- Probes And Drugs ID
- PD010064
- PubChem CID
- 6005
- Reaxys registry number
- 3653944, 29319
- RxNorm CUI
- 1043
- Römpp online ID
- RD-01-03011
- SPLASH
- splash10-000i-0090000000-052772c02bbf103a3ef5, splash10-00kr-0290000000-1e831a8078d43cfbdb51, splash10-000i-0090000000-49baaafc781fbd1a40ea, splash10-000i-0090000000-b2abd157ce4880c73d0b, splash10-000i-0090000000-b747e9bb748f801c3f50, splash10-000i-0090000000-1a55345a571167f3fca6, splash10-014i-0090000000-3fece537b8c97a28956b
- Store medisinske leksikon ID
- apomorfin
- SureChEMBL ID
- 8541
- UMLS CUI
- C0003596
- UNII
- N21FAR7B4S
- UniChem compound ID
- 162887
- WikiProjectMed ID
- Apomorphine
- WordNet 3.1 Synset ID
- 02730585-n
- Yale LUX ID
- concept/cc0fb4c8-4310-45ba-9dda-73adb699dddb
- Yle topic ID
- 18-249681
🔗 Connections
Significant drug interaction 25
haloperidol,
haloperidol,
chlorpromazine,
chlorpromazine,
quetiapine,
quetiapine,
ondansetron,
ondansetron
+17 more
← Significant drug interaction 25
haloperidol,
haloperidol,
chlorpromazine,
chlorpromazine,
quetiapine,
quetiapine,
ondansetron,
ondansetron
+17 more
← Physically interacts with 4
Physically interacts with 3
Subject has role 3
Described by source 1
Has use 1
Medical condition treated 1
Subclass of 1
← Drug or therapy used for treatment 1
Press Enter · cited answer in seconds